Table of Contents Author Guidelines Submit a Manuscript
Canadian Respiratory Journal
Volume 2016, Article ID 7980869, 6 pages
http://dx.doi.org/10.1155/2016/7980869
Research Article

A Step toward Tuberculosis Elimination in a Low-Incidence Country: Successful Diagnosis and Treatment of Latent Tuberculosis Infection in a Refugee Clinic

1Infectious Diseases, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada T6G 2G3
2Edmonton TB Clinic, Edmonton, AB, Canada T6G 2J3
3New Canadians Clinic, Edmonton, AB, Canada T5M 3Z7
4University of Alberta School of Public Health, Edmonton, AB, Canada T6G 1C9

Received 8 July 2015; Accepted 8 November 2015

Copyright © 2016 Elissa Rennert-May et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. J. Murray, K. F. Ortblad, C. Guinovart et al., “Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013,” The Lancet, vol. 384, no. 9947, pp. 1005–1070, 2014. View at Publisher · View at Google Scholar
  2. World Health Organization, “Tuberculosis Fact Sheet,” 2015, http://www.who.int/mediacentre/factsheets/fs104/en/.
  3. Public Health Agency of Canada, “Tuberculosis in Canada 2012,” http://www.phac-aspc.gc.ca/tbpc-latb/pubs/tbcan12pre/index-eng.php.
  4. World Health Organization and European Respiratory Society, “Framework towards TB elimination in low incidence countries,” 2014, http://www.who.int/tb/publications/Towards_TB_Eliminationfactsheet.pdf.
  5. D. Butler-Jones and A. Corriveau, Pan-Canadian Public Health Network: Guidance for Tuberculosis Prevention and Control Programs in Canada, 2012, http://www.phn-rsp.ca/pubs/gtbpcp-oppctbc/pdf/Guidance-for-Tuberculosis-Prevention-eng.pdf.
  6. P. M. Ricks, K. P. Cain, J. E. Oeltmann, J. S. Kammerer, and P. K. Moonan, “Estimating the burden of tuberculosis among foreign-born persons acquired prior to entering the U.S., 2005–2009,” PLoS ONE, vol. 6, no. 11, Article ID e27405, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Kunimoto, K. Sutherland, K. Wooldrage et al., “Transmission characteristics of tuberculosis in the foreign-born and the Canadian-born populations of Alberta, Canada,” International Journal of Tuberculosis and Lung Disease, vol. 8, no. 10, pp. 1213–1220, 2004. View at Google Scholar · View at Scopus
  8. E. Rea and P. Rivest, “Contact follow-up and outbreak management in tuberculosis control,” in Canadian Tuberculosis Standards, D. Menzies, Ed., pp. 108A–118A, Pulsus, Oakville, Canada, 7th edition, 2013. View at Google Scholar
  9. M. J. van der Werf and K. Lönnroth, “Pre-entry, post-entry, or no tuberculosis screening?” The Lancet Infectious Diseases, vol. 14, no. 12, pp. 1171–1172, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. Government of Canada, Citizenship and Immigration Canada, Fact and Figures 2014-Immigration overview: Permanent residents, 2015, http://www.cic.gc.ca/english/resources/statistics/facts2014/permanent/02.asp.
  11. World Health Organization, “Global Tuberculosis Control 2011,” http://apps.who.int/iris/bitstream/10665/44728/1/9789241564380_eng.pdf.
  12. K. Khan, M. M. Hirji, J. Miniota et al., “Domestic impact of tuberculosis screening among new immigrants to Ontario, Canada,” Canadian Medical Association Journal, vol. 187, no. 16, pp. E473–E481, 2015. View at Publisher · View at Google Scholar
  13. C. Greenaway, K. Khan, and K. Schwartzman, “Tuberculosis surveillance and screening in selected high-risk populations,” in Canadian Tuberculosis Standards, D. Menzies, Ed., pp. 119A–128A, Pulsus, Oakville, Canada, 7th edition, 2013. View at Google Scholar
  14. J. P. Morano, M. R. Walton, A. Zelenev, R. D. Bruce, and F. L. Altice, “Latent tuberculosis infection: screening and treatment in an urban setting,” Journal of Community Health, vol. 38, no. 5, pp. 941–950, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Menzies, “Immigration Subcommittee, Canadian Tuberculosis Committee. Screening immigrants to Canada for tuberculosis: chest radiography or tuberculin skin testing?” Canadian Medical Association Journal, vol. 169, no. 10, pp. 1035–1036, 2003. View at Google Scholar
  16. D. Menzies, G. Alvarez, and K. Khan, “Treatment of latent tuberculosis infection,” in Canadian Tuberculosis Standards, D. Menzies, Ed., pp. 44A–53A, Pulsus, Oakville, Canada, 7th edition, 2013. View at Google Scholar
  17. N. N. Alami, C. M. Yuen, R. Miramontes, R. Pratt, S. F. Price, and T. R. Navin, “Trends in tuberculosis—United States, 2013,” Morbidity and Mortality Weekly Report, vol. 63, no. 11, pp. 229–233, 2014. View at Google Scholar · View at Scopus
  18. C. Greenaway, A. Sandoe, B. Vissandjee et al., “Tuberculosis: evidence review for newly arriving immigrants and refugees,” Canadian Medical Association Journal, vol. 183, no. 12, pp. E939–E951, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. O. Oxlade, K. Schwartzman, and D. Menzies, “Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis,” International Journal of Tuberculosis and Lung Disease, vol. 11, no. 1, pp. 16–26, 2007. View at Google Scholar · View at Scopus
  20. F. Marra, C. A. Marra, M. Sadatsafavi et al., “Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts,” International Journal of Tuberculosis and Lung Disease, vol. 12, no. 12, pp. 1414–1424, 2008. View at Google Scholar · View at Scopus
  21. N. D. Goswami, L. B. Gadkowski, C. Piedrahita et al., “Predictors of latent tuberculosis treatment initiation and completion at a U.S. public health clinic: a prospective cohort study,” BMC Public Health, vol. 12, no. 1, article 468, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. P. W. Colson, Y. Hirsch-Moverman, J. Bethel et al., “Acceptance of treatment for latent tuberculosis infection: prospective cohort study in the United States and Canada,” International Journal of Tuberculosis and Lung Disease, vol. 17, no. 4, pp. 473–479, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. J.-F. Levesque, P. Dongier, P. Brassard, and R. Allard, “Acceptance of screening and completion of treatment for latent tuberculosis infection among refugee claimants in Canada,” International Journal of Tuberculosis and Lung Disease, vol. 8, no. 6, pp. 711–717, 2004. View at Google Scholar · View at Scopus
  24. N. Bettache, K. Schwartzman, S. Cnossen et al., “Effectiveness of post-arrival latent tuberculosis screening programs in the foreign born: a systematic review and meta-analysis,” in Proceedings of the American Thoracic Society 2012 International Conference, vol. 185, A3325, American Thoracic Society, San Francisco, Calif, USA, May 2012.
  25. C. B.-E. Chee, M. Sester, W. Zhang, and C. Lange, “Diagnosis and treatment of latent infection with Mycobacterium tuberculosis,” Respirology, vol. 18, no. 2, pp. 205–216, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. Centers for Disease Control and Prevention (CDC), “TB elimination, treatment options for latent tuberculosis infection fact sheet,” 2011, http://www.cdc.gov/tb/publications/factsheets/treatment/ltbitreatmentoptions.htm.
  27. R. Diel, R. Loddenkemper, and A. Nienhaus, “Predictive value of interferon-γ release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis,” Chest, vol. 142, no. 1, pp. 63–75, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. J. R. Campbell Jr., J. Krot, K. Elwood, V. Cook, and F. Marra, “A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants,” Molecular Diagnosis & Therapy, vol. 19, no. 1, pp. 9–24, 2015. View at Publisher · View at Google Scholar
  29. J. R. Campbell, W. Chen, J. Johnston et al., “Latent tuberculosis infection screening in immigrants to low-incidence countries: a meta-analysis,” Molecular Diagnosis & Therapy, vol. 19, no. 2, pp. 107–117, 2015. View at Publisher · View at Google Scholar
  30. Canadian Tuberculosis Committee, Recommendations on Interferon Gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection—2010 Update, 2010, http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/10pdf/36-acs-5.pdf.
  31. C. R. Horsburgh and E. J. Rubin, “Clinical practice: latent tuberculosis infection in the United States,” The New England Journal of Medicine, vol. 364, no. 15, pp. 1441–1448, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Menzies, R. Long, A. Trajman et al., “Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection: a randomized trial,” Annals of Internal Medicine, vol. 149, no. 10, pp. 689–697, 2008. View at Publisher · View at Google Scholar · View at Scopus